BE
₹1,806.60
-43.10(-2.33%)
BETA₹1,806.60-2.33%
Value & Investment Index
VIIVII Detail
90 days · zone the stock traded inMultiples vs Peers
Quality Scores
Versus Its Own History
P/E · P/B percentile bandsScenario analysis
stated assumptions, shown workingsBETA valuation summary
Beta Drugs Limited trades at 135.0 times trailing earnings. Return on equity is 10.3% and return on capital employed is 11.2%.
| P/E | 135.0 |
|---|---|
| ROE | 10.3% |
| ROCE | 11.2% |